Drugmakers Expect Coronavirus Vaccine Production to Start by End of Summer
US health officials and drugmakers are expecting the production of a coronavirus vaccine to begin by the end of summer, according to CNBC.
The US hopes to deliver 300 million doses of a vaccine for COVID-19 by early 2021. Today, a senior Trump administration official stated that manufacturing is already underway even though no candidate has been declared the vaccine winner. They are purchasing equipment, securing manufacturing sites, and acquiring materials. “Exactly when the vaccine materials will be in production and manufacturing? It’s probably four to six weeks away,” the official said. “But we will be actively manufacturing by the end of the summer.”
There are four potential vaccine candidates as of right now. Moderna and Johnson & Johnson are two of the bigger names involved in the development of vaccines. Both companies are expected to begin late-stage human trials by the end of this month. The vaccine development process has progressed in record-breaking time. However, scientists have stated there is no guarantee the vaccine will be effective.
As of Monday, the US has more than 3.3 million confirmed COVID-19 cases and at least 135, 205 deaths, according to data from Johns Hopkins University.